Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2025-12-25 @ 7:54 PM
Study NCT ID:
NCT05534035
Status:
UNKNOWN
Last Update Posted:
2022-09-09
First Post:
2022-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older
Sponsor:
Everest Medicines (Singapore) Pte. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10-18
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-06
First Submit QC Date:
None
Study First Post Date:
2022-09-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-07
Last Update Post Date:
2022-09-09
Last Update Post Date Type:
ACTUAL